Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print August 26, 2008
DOI: 10.2337/db08-0878

This Article
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
db08-0878v1
57/11/3069    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Ackermann Misfeldt, A.
Right arrow Articles by Gannon, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ackermann Misfeldt, A.
Right arrow Articles by Gannon, M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

β-Cell Proliferation, but not Neogenesis, Following 60% Partial Pancreatectomy is Impaired in the Absence of FoxM1

Amanda Ackermann Misfeldt, B.S2,4, Robert H. Costa, PhD5, and Maureen Gannon, PhD1,2,3,4

1Department of Medicine, Division of Diabetes, Endocrinology, and Metabolism, Vanderbilt University Medical Center, Nashville, Tennessee
2Department of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, Tennessee
3Department of Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, Tennessee
4Program in Developmental Biology, Vanderbilt University Medical Center, Nashville, Tennessee
5Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, Illinois

Objective: This study was designed to determine whether the transcription factor FoxM1 was required for regeneration of β-cell mass via proliferation and/or neogenesis in the adult after 60% partial pancreatectomy (PPx).

Research Design and Methods: Adult mice with a pancreas-wide deletion of Foxm1 (Foxm1flox/flox;Pdx1-Cre [FoxM1{Delta}panc]) and their Control littermates (Foxm1flox/flox) were subjected to PPx or a Sham operation, after which islet expression of Foxm1 and several target genes, β-cell mass, proliferation, β-cell size, islet size, islet density, and Neurogenin3 expression were analyzed.

Results: In Control mice, PPx stimulated β-cell proliferation and neogenesis and up-regulated Foxm1 and several of its known targets (Plk1, Cenp-a, Birc5/Survivin, Ccnb1) in islets. Within 1 week post-PPx, Control mice underwent significant regeneration of β-cell mass, and average islet size within the regenerating lobe was similar to that after a sham operation. However, FoxM1{Delta}panc mice exhibited specific impairments in β-cell mass regeneration and islet growth after PPx, with reduced proliferation of {alpha} and β-cells but no impairments in acinar or ductal cell proliferation. Interestingly, FoxM1 was not required for proliferation of β-cells within small endocrine cell clusters located in the regenerating portion of the pancreas, but was specifically required for proliferation of β-cells within larger islets. Additionally, FoxM1 was not required for β-cell neogenesis following PPx.

Conclusions: Our results indicate that FoxM1 is partially required for increased β-cell proliferation, but not β-cell neogenesis, stimulated by PPx. Furthermore, FoxM1 seems to be dispensable for proliferation of β-cells following neogenesis but is required for proliferation of pre-existing β-cells.


Correspondence: maureen.gannon{at}vanderbilt.edu


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.